Evidence map›Paper›PMID 24331031›Full record

ArticleEpidemiology and infection2014

Serological survey of a new type of reovirus in humans in China.

B Bai, H Shen, Y Hu, J Hou, Z Liu, R Li, Y Chai, W Huang, P Mao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

B BaiDepartment of Virology, Institute of Infectious Disease, 302 Hospital, Beijing,PR China.
H ShenDepartment of Virology, Institute of Infectious Disease, 302 Hospital, Beijing,PR China.
Y HuDepartment of Virology, Institute of Infectious Disease, 302 Hospital, Beijing,PR China.
J HouDepartment of Virology, Institute of Infectious Disease, 302 Hospital, Beijing,PR China.
Z LiuTreatment and Research Centre for Liver Cancer, 302 Hospital, Beijing,PR China.
R LiDepartment of Virology, Institute of Infectious Disease, 302 Hospital, Beijing,PR China.
Y ChaiDepartment of Virology, Institute of Infectious Disease, 302 Hospital, Beijing,PR China.
W HuangDepartment of Virology, Institute of Infectious Disease, 302 Hospital, Beijing,PR China.
P MaoDepartment of Virology, Institute of Infectious Disease, 302 Hospital, Beijing,PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate the presence of a new type of reovirus (designated R4) in humans, we determined the prevalence of specific antibodies using a neutralization assay and ELISA. The sera from 97 healthy people and 219 patients in our hospital with measles, hand-foot-and-mouth disease, liver diseases, and diarrhoea were investigated. Although the study population was limited, our data suggested that R4 is widespread in the human population. A significantly higher level of R4-specific antibody in patients than in healthy people is worthy of consideration, since it poses a risk for aggravation of the extant illness by the reovirus.

Indexed as

AdolescentAdultAntibodies, NeutralizingAntibodies, ViralCase-Control StudiesChildChild, PreschoolChinaDiarrheaEnzyme-Linked Immunosorbent AssayFemaleHand, Foot and Mouth DiseaseHealthy VolunteersHumansLiver DiseasesMaleAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID24331031
PMCPMC9151255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.